News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
241 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (240)
2 (57)
3 (1)
4 (1)
5 (18)
6 (241)
7 (241)
8 (238)
9 (112)
10 (3)
11 (4)
12 (212)
13 (193)
14 (224)
15 (199)
16 (95)
17 (5)
18 (3)
19 (174)
20 (211)
21 (192)
22 (230)
23 (101)
24 (8)
25 (6)
26 (208)
27 (213)
28 (252)
29 (279)
30 (110)
31 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
COVID-19 News: New Variants, Third Doses and More
Continuing studies and news about COVID-19 around the world keeps coming in. Here’s a look.
July 6, 2021
·
4 min read
·
Mark Terry
Policy
GSK Supports CEO Against Activist Shareholder’s Demands
The board strongly believes that Walmsley is the correct leader for the pharmaceutical business arm of GSK, which is being referred to as New GSK.
July 6, 2021
·
3 min read
·
Alex Keown
Business
GSK and Alector Partner to Develop Immuno-Neurology Treatments
The two antibody candidates, AL001 and AL101, are seen as potential first-in-class medications aimed at a range of neurodegenerative diseases.
July 6, 2021
·
3 min read
·
Alex Keown
Business
Culturally Nimble CEO Ready to Lead D&D Pharmatech
With business taking him throughout North and South America, Asia, and Europe, he’s learned to adapt and appreciate the nuances of a multicultural environment.
July 6, 2021
·
6 min read
·
Gail Dutton
Deals
Let Freedom Ring on the NASDAQ – Four Companies File for IPOs
Tossing their names in the hat just before long weekend, four life sciences companies filed for $100 million IPOs Friday afternoon.
July 6, 2021
·
4 min read
·
Kate Goodwin
FDA
FDA Says ‘Not So Fast’ to Drug for Delaying Type 1 Diabetes
The FDA issued Provention a CRL that focuses on a single low-dose pharmacokinetic/pharmacodynamic (PK/PD) bridging study in health volunteers.
July 6, 2021
·
2 min read
·
Mark Terry
Career Advice
17 Useful Career Advice and Tips to Advance in Your Job
Being confident about your skills and learning new things are some of the best career advice and tips a professional should know to become better at your workplace.
July 6, 2021
·
4 min read
·
Lorenzo Soliman
Deals
Global Clinical Research Firm Parexel to Be Acquired for $8.5 Billion
Upon completion of the merger, Parexel will be owned by EQT IX Fund and the private equity business within Goldman Sachs Asset Management.
July 6, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development
FDA Expands Approval for Keytruda in Locally Advanced Cutaneous SCC
The expanded approval was made based on positive data from a second interim analysis of the Phase II KEYNOTE-629 trial.
July 6, 2021
·
2 min read
·
Brandon May
BioMidwest
Boehringer, Lilly: Jardiance Significantly Reduced CV Death and HF-Related Hospitalization in HFpEF
Jardiance most recently received approval by the European Commission for the treatment of adult patients with HF with ejection fraction, based on findings from the EMPEROR-Reduced trial.
July 6, 2021
·
3 min read
·
Brandon May
1 of 25
Next